loadpatents
Patent applications and USPTO patent grants for Rudnic; Edward M..The latest application filed is for "oral cannabinoid pharmaceutical compositions and methods of treating sleep disorders".
Patent | Date |
---|---|
Oral Cannabinoid Pharmaceutical Compositions And Methods Of Treating Sleep Disorders App 20220249429 - Rudnic; Edward M. ;   et al. | 2022-08-11 |
Disposal of medicaments Grant 10,532,385 - Schestopol , et al. Ja | 2020-01-14 |
Disposal Of Medicaments App 20190358687 - Schestopol; Marcus ;   et al. | 2019-11-28 |
Disposal Of Medicaments App 20180001357 - SCHESTOPOL; MARCUS ;   et al. | 2018-01-04 |
Once a day amoxicillin product comprising immediate and delayed release dosage forms Grant 8,889,187 - Rudnic , et al. November 18, 2 | 2014-11-18 |
Device for Disposing Medicament Products App 20140183070 - Holaday; John W. ;   et al. | 2014-07-03 |
Device for Disposal and Neutralization of Pharmaceutical Agents App 20140187842 - Holaday; John W. ;   et al. | 2014-07-03 |
Controlled Release Formulations of Opioids App 20130022646 - Rudnic; Edward M. ;   et al. | 2013-01-24 |
Technology For Preventing Abuse Of Solid Dosage Forms App 20120321716 - VACHON; Michael ;   et al. | 2012-12-20 |
Technology for Preventing Abuse of Solid Dosage Forms App 20120321674 - Vachon; Michael ;   et al. | 2012-12-20 |
Antifungal once-a-day product, use and formulation thereof Grant 8,303,988 - Rudnic , et al. November 6, 2 | 2012-11-06 |
Antibiotic Product, Use And Formulation Thereof App 20120035121 - Rudnic; Edward M. ;   et al. | 2012-02-09 |
Controlled Release Formulations of Opioids App 20110195989 - Rudnic; Edward M. ;   et al. | 2011-08-11 |
Antifungal Product, Use and Formulation Thereof App 20110065718 - Rudnic; Edward M. ;   et al. | 2011-03-17 |
Oral pulsed dose drug delivery system Grant RE42,096 - Burnside , et al. February 1, 2 | 2011-02-01 |
Once-A-Day RNA-Polymerase inhibiting and elongation factor G (EF-G) inhibiting antibiotic pharmaceutical product, formulation thereof, and use thereof in treating infection caused by methicillin-resistant staphylococcus aureus App 20100120896 - Sander; Sanna ;   et al. | 2010-05-13 |
Oral pulsed dose drug delivery system Grant RE41,148 - Burnside , et al. February 23, 2 | 2010-02-23 |
Once-a-day (RNA-Polymerase Inhibiting or phenazine) - dihydropteroate synthase inhibiting - dihydrofolate reductase inhibiting antibiotic pharmaceutical product, formulation thereof, and use thereof in treating infection caused by Methicillin-Resistant Staphylococcus aureus App 20100016333 - Flanner; Henry H. ;   et al. | 2010-01-21 |
Antiviral product, use and formulation thereof Grant 7,282,221 - Rudnic , et al. October 16, 2 | 2007-10-16 |
Multiple-delayed release antifungal product, use and formulation thereof Grant 7,157,095 - Rudnic , et al. January 2, 2 | 2007-01-02 |
Antibiotic composition with inhibitor Grant 7,122,204 - Rudnic October 17, 2 | 2006-10-17 |
Antineoplastic product, use and formulation thereof Grant 7,108,859 - Rudnic , et al. September 19, 2 | 2006-09-19 |
Multiple-delayed release anti-neoplastic product, use and formulation thereof Grant 7,105,174 - Rudnic , et al. September 12, 2 | 2006-09-12 |
Multiple-delayed release anti-viral product, use and formulation thereof Grant 7,074,417 - Rudnic , et al. July 11, 2 | 2006-07-11 |
Antiviral product, use and formulation thereof App 20060110455 - Rudnic; Edward M. ;   et al. | 2006-05-25 |
Multiple-delayed released antibiotic product, use and formulation thereof Grant 7,025,989 - Rudnic , et al. April 11, 2 | 2006-04-11 |
Antibiotic composition Grant 6,991,807 - Rudnic , et al. January 31, 2 | 2006-01-31 |
Antiviral product, use and formulation thereof Grant 6,984,401 - Rudnic , et al. January 10, 2 | 2006-01-10 |
Anti-fungal composition App 20050238714 - Rudnic, Edward M. ;   et al. | 2005-10-27 |
Anti-fungal composition Grant 6,929,804 - Rudnic , et al. August 16, 2 | 2005-08-16 |
Pulsatile transdermally administered antigens and adjuvants App 20040253249 - Rudnic, Edward M. ;   et al. | 2004-12-16 |
Osmotic drug delivery system Grant 6,814,979 - Rudnic , et al. November 9, 2 | 2004-11-09 |
Oral pulsed dose drug delivery system App 20040219213 - Burnside, Beth A. ;   et al. | 2004-11-04 |
Tetracycline antibiotic product, use and formulation thereof Grant 6,730,320 - Rudnic , et al. May 4, 2 | 2004-05-04 |
Antibiotic product, use and formulation thereof Grant 6,723,341 - Rudnic , et al. April 20, 2 | 2004-04-20 |
Antibiotic product, use and formulation thereof App 20040052842 - Rudnic, Edward M. ;   et al. | 2004-03-18 |
Solid solution beadlet Grant 6,692,767 - Burnside , et al. February 17, 2 | 2004-02-17 |
Antibiotic composition App 20040018234 - Rudnic, Edward M. ;   et al. | 2004-01-29 |
Antibiotic product, use and formulation thereof Grant 6,669,948 - Rudnic , et al. December 30, 2 | 2003-12-30 |
Antibiotic composition with inhibitor App 20030235615 - Rudnic, Edward M. | 2003-12-25 |
Levofloxacin antibiotic product, use and formulation thereof Grant 6,667,057 - Rudnic , et al. December 23, 2 | 2003-12-23 |
Fluroquinilone antibiotic product, use and formulation thereof Grant 6,667,042 - Rudnic , et al. December 23, 2 | 2003-12-23 |
Erythromyacin antibiotic product, use and formulation thereof Grant 6,663,891 - Rudnic , et al. December 16, 2 | 2003-12-16 |
Metronidazole antibiotic product, use and formulation thereof Grant 6,663,890 - Rudnic , et al. December 16, 2 | 2003-12-16 |
Antibiotic product, use and formulation thereof App 20030206951 - Rudnic, Edward M. ;   et al. | 2003-11-06 |
Anti-fungal composition App 20030203023 - Rudnic, Edward M. ;   et al. | 2003-10-30 |
Tetracycline--doxycycline antibiotic composition Grant 6,638,532 - Rudnic , et al. October 28, 2 | 2003-10-28 |
Ciprofoxacin-metronidazole antibiotic composition Grant 6,632,453 - Rudnic , et al. October 14, 2 | 2003-10-14 |
Amoxicillin-dicloxacillin antibiotic composition Grant 6,627,222 - Rudnic , et al. September 30, 2 | 2003-09-30 |
Cephalosporin-metronidazole antibiotic composition Grant 6,623,758 - Rudnic , et al. September 23, 2 | 2003-09-23 |
Antibiotic composition Grant 6,623,757 - Rudnic , et al. September 23, 2 | 2003-09-23 |
Amoxicillin-clarithromycin antibiotic composition Grant 6,610,328 - Rudnic , et al. August 26, 2 | 2003-08-26 |
Oral pulsed dose drug delivery system Grant 6,605,300 - Burnside , et al. August 12, 2 | 2003-08-12 |
Delayed release anti-fungal product, use and formulation thereof App 20030147953 - Rudnic, Edward M. ;   et al. | 2003-08-07 |
Soluble form osmotic dose delivery system App 20030143273 - Rudnic, Edward M. ;   et al. | 2003-07-31 |
Oral pulsed dose drug delivery system App 20030124188 - Burnside, Beth A. ;   et al. | 2003-07-03 |
Antineoplastic product, use and formulation thereof App 20030104058 - Rudnic, Edward M. ;   et al. | 2003-06-05 |
Delayed release anti-neoplastic product, use and formulation thereof App 20030104054 - Rudnic, Edward M. ;   et al. | 2003-06-05 |
Antibiotic product, use and formulation thereof App 20030104055 - Rudnic, Edward M. ;   et al. | 2003-06-05 |
Delayed release anti-viral product, use and formulation thereof App 20030104056 - Rudnic, Edward M. ;   et al. | 2003-06-05 |
Antiviral product, use and formulation thereof App 20030099706 - Rudnic, Edward M. ;   et al. | 2003-05-29 |
Antifungal product, use and formulation thereof App 20030099707 - Rudnic, Edward M. ;   et al. | 2003-05-29 |
Tetracycline - Doxycycline antibiotic composition App 20030096008 - Rudnic, Edward M. ;   et al. | 2003-05-22 |
Cephalosporin-metronidazole antibiotic composition App 20030096006 - Rudnic, Edward M. ;   et al. | 2003-05-22 |
Amoxicillin-dicloxacillin antibiotic composition App 20030096007 - Rudnic, Edward M. ;   et al. | 2003-05-22 |
Ciprofoxacin-metronidazole antibiotic composition App 20030086969 - Rudnic, Edward M. ;   et al. | 2003-05-08 |
Amoxicillin - clarithromycin antibiotic composition App 20030077323 - Rudnic, Edward M. ;   et al. | 2003-04-24 |
Metronidazole antibiotic product, use and formulation thereof App 20030064100 - Rudnic, Edward M. ;   et al. | 2003-04-03 |
Soluble form osmotic dose delivery system Grant 6,514,532 - Rudnic , et al. February 4, 2 | 2003-02-04 |
Levofloxacin antibiotic product, use and formulation thereof App 20030012814 - Rudnic, Edward M. ;   et al. | 2003-01-16 |
Anti-fungal composition App 20020197314 - Rudnic, Edward M. ;   et al. | 2002-12-26 |
Erythromyacin antibiotic product, use and formulation thereof App 20020150619 - Rudnic, Edward M. ;   et al. | 2002-10-17 |
Tetracycline antibiotic product, use and formulation thereof App 20020136766 - Rudnic, Edward M. ;   et al. | 2002-09-26 |
Fluroquinilone antibiotic product, use and formulation thereof App 20020136765 - Rudnic, Edward M. ;   et al. | 2002-09-26 |
Antibiotic product, use and formulation thereof App 20020136764 - Rudnic, Edward M. ;   et al. | 2002-09-26 |
Therapeutic agent delivery App 20020119168 - Rudnic, Edward M. ;   et al. | 2002-08-29 |
Soluble form osmotic dose delivery system App 20020102306 - Rudnic, Edward M. ;   et al. | 2002-08-01 |
Antiviral product, use and formulation thereof App 20020068085 - Rudnic, Edward M. ;   et al. | 2002-06-06 |
Antifungal product, use and formulation thereof App 20020068078 - Rudnic, Edward M. ;   et al. | 2002-06-06 |
Soluble form osmotic dose delivery system Grant 6,361,796 - Rudnic , et al. March 26, 2 | 2002-03-26 |
Antibiotic composition App 20020004499 - Rudnic, Edward M. ;   et al. | 2002-01-10 |
Antineoplastic product, use and formulation thereof App 20020004070 - Rudnic, Edward M. ;   et al. | 2002-01-10 |
Oral Pulsed Dose Drug Delivery System App 20010055613 - BURNSIDE, BETH A. ;   et al. | 2001-12-27 |
Antibiotic product, use and formulation thereof App 20010048944 - Rudnic, Edward M. ;   et al. | 2001-12-06 |
Antibiotic composition with inhibitor App 20010046984 - Rudnic, Edward M. | 2001-11-29 |
Oral pulsed dose drug delivery system Grant 6,322,819 - Burnside , et al. November 27, 2 | 2001-11-27 |
Soluble form osmotic dose delivery system Grant 6,284,276 - Rudnic , et al. September 4, 2 | 2001-09-04 |
Solid Solution Beadlet App 20010006650 - BURNSIDE, BETH A. ;   et al. | 2001-07-05 |
Osmotic drug delivery system Grant 6,110,498 - Rudnic , et al. August 29, 2 | 2000-08-29 |
Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine Grant 5,912,013 - Rudnic , et al. June 15, 1 | 1999-06-15 |
Emulsified drug delivery system Grant 5,897,876 - Rudnic , et al. April 27, 1 | 1999-04-27 |
Oral acyclovir delivery Grant 5,883,103 - Burnside , et al. March 16, 1 | 1999-03-16 |
Oral insulin delivery Grant 5,824,638 - Burnside , et al. October 20, 1 | 1998-10-20 |
Sustained-release drug delivery system Grant 5,484,608 - Rudnic , et al. January 16, 1 | 1996-01-16 |
Multilamellar drug delivery systems Grant 5,447,729 - Belenduik , et al. September 5, 1 | 1995-09-05 |
Hydrophobic drug delivery systems Grant 5,430,021 - Rudnic , et al. July 4, 1 | 1995-07-04 |
Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine Grant 5,326,570 - Rudnic , et al. July 5, 1 | 1994-07-05 |
Transdermal nitroglycerin patch with penetration enhancers Grant 5,262,165 - Govil , et al. November 16, 1 | 1993-11-16 |
Sustained release oral suspensions Grant 5,186,930 - Kogan , et al. February 16, 1 | 1993-02-16 |
Potassium/magnesium supplement Grant 5,035,898 - Chang , et al. * July 30, 1 | 1991-07-30 |
Sustained release oral suspensions Grant 4,999,189 - Kogan , et al. March 12, 1 | 1991-03-12 |
Controlled release formulation Grant 4,666,705 - DeCrosta , et al. May 19, 1 | 1987-05-19 |
Controlled release formulation Grant 4,610,870 - Jain , et al. September 9, 1 | 1986-09-09 |
Drug delivery systems including novel interpenetrating polymer networks and method Grant 4,575,539 - DeCrosta , et al. March 11, 1 | 1986-03-11 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.